GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Unsecured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Unsecured Loans | ₹78 Cr | ₹107 Cr | ₹3.26 Cr | ₹3.82 Cr | ₹3.93 Cr |
What is the latest Unsecured Loans ratio of GLAND PHARMA ?
| Year | Unsecured Loans |
|---|---|
| Mar2025 | ₹78 Cr |
| Mar2024 | ₹107 Cr |
| Mar2023 | ₹3.26 Cr |
| Mar2022 | ₹3.82 Cr |
| Mar2021 | ₹3.93 Cr |
How is Unsecured Loans of GLAND PHARMA Trending?
| Years | Unsecured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹78 Cr | -27.10 | |
| Mar2024 | ₹107 Cr | 3,167.10 | |
| Mar2023 | ₹3.26 Cr | -14.66 | |
| Mar2022 | ₹3.82 Cr | -2.87 | |
| Mar2021 | ₹3.93 Cr | - | |
Compare Unsecured Loans of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹39,242.8 Cr | -3.3% | 2.3% | 18.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -3.3% |
2.3% |
18.4% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses